Literature DB >> 24182776

Informed consent: what the patient heard.

O S Surman1.   

Abstract

UNLABELLED: Transplant Psychiatrist: "Why is it important to take (routine) medications after transplantation?" Transplant candidate: "To protect the liver." Doctor: "How?" PATIENT: "I don't know." Doctor: "Think about it for a moment." PATIENT: "To prevent rejection and infection." Doctor: "Which one: rejection or infection?" PATIENT: "Both." This article reports significant conceptual limitations in patient medical knowledge. In the course of customary comprehensive psychiatric evaluation, patients with end-stage renal and/or hepatic disease were asked about knowledge of benefits and side effects of required post-transplant medication. Liver transplant candidates were asked about their understanding of primary organ function and instructed in reference to components of Model for End-stage Liver Disease status on the deceased donor transplant list. Candidates for renal transplantation were selectively asked about risks regarding medical dietary compliance, including dangers of hyperkalemia. PATIENTs had less than expected understanding of required immunosuppression. Liver transplant candidates, with infrequent exception, described the organ as a filter. Those with medical compliance problems related to end-stage renal disease had limited understanding of the kidney's role in homeostasis and impact of hyperkalemia on neurologic function. Additional teaching centered on narrative and analogy specific to individual life experience and skills. Historical reference to Sir Peter Medawar's Nobel Prize-winning work on skin allograft failure for treatment of World War II burn victims effectively illustrated the primacy of immunosuppression for successful organ transplantation. PATIENTs were receptive to this teaching approach. Many expressed gratitude for improved understanding. Clinical awareness of patient skills and life experience can enrich understanding of transplantation objectives and importance of medical compliance.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24182776     DOI: 10.1016/j.transproceed.2013.03.053

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

1.  Randomised controlled trial of a video intervention and behaviour contract to improve medication adherence after renal transplantation: the VECTOR study protocol.

Authors:  Holly Mansell; Nicola Rosaasen; Patricia West-Thielke; Jenny Wichart; Christopher Daley; Rahul Mainra; Ahmed Shoker; Juxin Liu; David Blackburn
Journal:  BMJ Open       Date:  2019-03-13       Impact factor: 2.692

2.  Living Kidney Donor Knowledge of Provided Information and Informed Consent: The PRINCE Study.

Authors:  Emerentia Q W Spoon; Kirsten Kortram; Sohal Y Ismail; Daan Nieboer; Frank C H d'Ancona; Maarten H L Christiaans; Ruth E Dam; Hendrik Sijbrand Hofker; Arjan W J Hoksbergen; Karlijn Ami van der Pant; Raechel J Toorop; Jacqueline van de Wetering; Jan N M Ijzermans; Frank J M F Dor
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

3.  Towards a standardised informed consent procedure for live donor nephrectomy: the PRINCE (Process of Informed Consent Evaluation) project-study protocol for a nationwide prospective cohort study.

Authors:  Kirsten Kortram; Emerentia Q W Spoon; Sohal Y Ismail; Frank C H d'Ancona; Maarten H L Christiaans; L W Ernest van Heurn; H Sijbrand Hofker; Arjan W J Hoksbergen; Jaap J Homan van der Heide; Mirza M Idu; Caspar W N Looman; S Azam Nurmohamed; Jan Ringers; Raechel J Toorop; Jacqueline van de Wetering; Jan N M Ijzermans; Frank J M F Dor
Journal:  BMJ Open       Date:  2016-04-01       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.